Protagonist Therapeutics, Inc. · NASDAQ:PTGX
Ali Asif sold 58,629 Protagonist Therapeutics, Inc. shares (Form 4)
Traded Sep 30, 2026 · Filed Oct 2, 2026
On Sep 30, 2026, Ali Asif (Chief Financial Officer) sold 58,629 Protagonist Therapeutics, Inc. shares at an average US$141.78 for US$8.31M under a trading plan, leaving 59,003 shares. Filed Oct 2, 2026 (Form 4).
- Sold
- 58,629 shares
- Price
- US$141.78 average (US$141.77 to US$141.78)
- Value
- US$8.31M
- Holding after
- 59,003 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Common Stock | Option exercise | 9,229 | US$38.98 | 68,232 | Direct |
| Sep 30, 2026 | Common Stock | Option exercise | 28,438 | US$23.42 | 96,670 | Direct |
| Sep 30, 2026 | Common Stock | Option exercise | 15,650 | US$19.19 | 112,320 | Direct |
| Sep 30, 2026 | Common Stock | Option exercise | 5,312 | US$12.17 | 117,632 | Direct |
| Sep 30, 2026 | Common Stock | Sale | 12,595 | US$141.77 | 105,037 | Direct |
| Sep 30, 2026 | Common Stock | Sale | 46,034 | US$141.78 | 59,003 | Direct |
Source
Related
- Protagonist Therapeutics, Inc.
- Ali Asif
- Protagonist Therapeutics, Inc. shareholders
- Form 4 · Ali Asif · Apr 21, 2026
- Form 4 · Patel Dinesh V Ph D · Sep 10, 2026
- Form 4 · Patel Dinesh V Ph D · Sep 8, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026
- Form 4 · Patel Dinesh V Ph D · Aug 12, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026